La Jolla Pharmaceutical PEG Ratio

La Jolla Pharmaceutical (LJPC) currently reports a PEG ratio of -31.25. That is below the Healthcare sector average of 11.64. Use the charts on this page to explore La Jolla Pharmaceutical's PEG ratio history and peer comparisons.

La Jolla Pharmaceutical's PEG ratio of -31.25 is lower than the Healthcare sector average of 11.64. That is roughly 368.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates La Jolla Pharmaceutical's market price to a fundamental measure such as earnings, sales, or book value. At -31.25, LJPC can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -31.25, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.64. From there, open related valuation or income-statement pages for La Jolla Pharmaceutical, and consider following LJPC for alerts when major investors trade the stock.

La Jolla Pharmaceutical is classified in the Healthcare sector. On PEG ratio, it currently shows -31.25 versus a sector average near 11.64. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LJPC with unrelated industries.